A Study to Assess the Tolerability and Safety of Subcutaneously (SC) Administered Immunoglobulin G (IgG) With Varying Injection Conditions
Clinical trial NCT07025577 · COMPLETED
Trial details
- NCT number
- NCT07025577
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-02
- Primary completion
- 2025-08-08
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.